Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Ciptarana Medika TbkISX:DKHH -1.41%2 14-Day RSI is 56.68 as of Sep. 12, 2026. GuruFocus rates ISX:DKHH with a GF Score™ of 2/100. The stock has 1 warning sign investors should review. Among 698 Healthcare Providers & Services companies, PT Ciptarana Medika Tbk ranks worse than 86.25% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
The industry rank for PT Ciptarana Medika Tbk's 14-Day RSI or its related term are showing as below:
ISX:DKHH's 14-Day RSI is ranked worse than 86.25% of 698
companies
in the Healthcare Providers & Services industry
Industry Median: 47.245
vs ISX:DKHH: 56.68
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
PT Ciptarana Medika Tbk 14-Day RSI Related Terms
ISX:DKHH vs HCA, THC, EHC: 14-Day RSI Comparison
For the Medical Care Facilities subindustry, PT Ciptarana Medika Tbk's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Ciptarana Medika Tbk 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Ciptarana Medika Tbk's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where PT Ciptarana Medika Tbk's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Ciptarana Medika Tbk (ISX:DKHH) has a 14-Day RSI of 56.68 as of Sep. 12, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on PT Ciptarana Medika Tbk and its competitors. According to the industry distribution chart, PT Ciptarana Medika Tbk ranks #602 out of 698 companies in the Healthcare Providers & Services industry, placing it in the top 86.2%.
Is PT Ciptarana Medika Tbk's 14-Day RSI too high?
PT Ciptarana Medika Tbk's current 14-Day RSI is 56.68. The Healthcare Providers & Services industry median 14-Day RSI is 47.25. PT Ciptarana Medika Tbk's value of 56.68 is 20% above this industry median. Based on the distribution chart, PT Ciptarana Medika Tbk ranks #602 out of 698 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, PT Ciptarana Medika Tbk has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does PT Ciptarana Medika Tbk's 14-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Ciptarana Medika Tbk ranks #602 out of 698 companies for 14-Day RSI. This places PT Ciptarana Medika Tbk in the lower half of its industry. The industry median 14-Day RSI is 47.25. PT Ciptarana Medika Tbk's value of 56.68 is 20% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 47.25, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Ciptarana Medika Tbk's current 14-Day RSI of 56.68 is 20% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on PT Ciptarana Medika Tbk and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 47.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Ciptarana Medika Tbk's current 14-Day RSI is 56.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Ciptarana Medika Tbk stock overvalued right now?
PT Ciptarana Medika Tbk (ISX:DKHH) has a current 14-Day RSI of 56.68. The current 14-Day RSI is 56.68 and 20% above the Healthcare Providers & Services industry median of 47.25. PT Ciptarana Medika Tbk's overall GF Score™ is 2/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For PT Ciptarana Medika Tbk (ISX:DKHH), the current 14-Day RSI is 56.68 as of Sep. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Cipta Sarana Medika Tbk is a private hospital and part of the Djajakusumah Health Care Group. The company earns revenue from sale of medicine and medical supplies, when delivered to the patients.
2GF Score
Get the complete analysis for ISX:DKHH
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:DKHH has been successfully added to your 
